ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.29
-0.48%
US Tech 100
19,827.03
0.94%
S&P 500
5,560.22
0.93%
US Dollar vs CAD
1.36425
0.19%
Bitcoin
56,709.39
-0.48%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eucrates Biomedical Acquisition Corporation (EUCRU)

  7. Eucrates Biomedical Acquisition Corporation (EUCRU) News

EUCRU

Eucrates Biomedical Acqu... (EUCRU)

Eucrates Biomedical Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EUCRU
DateTimeSourceHeadlineSymbolCompany
04/26/20233:53PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
04/11/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
04/03/20233:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
03/29/20233:41PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
02/16/20233:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
02/10/20238:44AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
11/14/20224:37PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
11/08/20223:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
10/31/20223:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
10/05/20224:21PMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
05/16/20223:50PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
04/11/20225:04AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
02/14/20221:43PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
02/08/20224:17PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
01/26/20223:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
12/20/20213:34PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
11/22/20213:33PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
11/16/20215:05AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
08/16/20212:27PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
07/16/20213:07PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
07/15/20214:29PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
06/21/20213:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
05/17/20216:33AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
03/31/20213:03PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
02/12/20213:04PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
02/08/20215:02AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
12/14/20204:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
12/14/20204:22PMPR Newswire (US)Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable WarrantsNASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
12/07/20204:26PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
10/27/20203:17PMPR Newswire (US)Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public OfferingNASDAQ:EUCRUEucrates Biomedical Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:EUCRU

Your Recent History

NASDAQ
NVDA
NVIDIA
USOTC
ERHE
ERHC Energy (CE)
USOTC
ENZC
Enzolytics (PK)
USOTC
SPZI
Spooz (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
COIN
BTCUSD
Bitcoin
NASDAQ
TSLA
Tesla
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
BLEG
Branded Legacy (PK)
USOTC
AXXA
Exxe (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
CYDY
CytoDyn (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved